Showing 1,181 - 1,200 results of 64,065 for search '(( 2 e decrease ) OR ( 50 ((((we decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.45s Refine Results
  1. 1181
  2. 1182
  3. 1183

    Anthelmintics Derived from the Kinase Inhibitor SGI-1776 for the Treatment of Gastrointestinal Worm Infections by Mostafa A. Elfawal (22430138)

    Published 2025
    “…Here, structure–activity relationship (SAR) studies were conducted to identify SGI-1776 analogs with improved cross-clade adulticidal activity (Ancylostoma ceylanicum hookworms and Trichuris muris whipworms). We further identified a new chemical series from <b>15</b> (imidazo[1,2-<i>b</i>]pyridazine-3-carboxamide) and novel derivatives from it. …”
  4. 1184
  5. 1185
  6. 1186
  7. 1187

    Disorder–Order Structural Transformation in Electron-Poor Sr<sub>3</sub>Au<sub>8</sub>Sn<sub>3</sub> Driven by Chemical Bonding Optimization by Qisheng Lin (1680814)

    Published 2013
    “…Single-crystal X-ray diffraction analyses revealed that Sr<sub>3</sub>Au<sub>8</sub>Sn<sub>3</sub> has a La<sub>3</sub>Al<sub>11</sub>-type <i>Immm</i> structure (<i>a</i> = 4.6767(8) Å, <i>b</i> = 9.646(2) Å, <i>c</i> = 14.170(2) Å, <i>Z</i> = 2) if annealed at 550 °C and above but a Ca<sub>3</sub>Au<sub>8</sub>Ge<sub>3</sub>-type structure (<i>Pnnm</i>, <i>a</i> = 9.6082(8) Å, <i>b</i> = 14.171(1) Å, <i>c</i> = 4.6719(4) Å, <i>Z</i> = 2) if annealed at 400 °C. …”
  8. 1188
  9. 1189
  10. 1190
  11. 1191
  12. 1192
  13. 1193
  14. 1194
  15. 1195

    The <i>P[syt<sup>P-L</sup>]</i> mutation decreases the Ca<sup>2+</sup> affinity of release and vesicular release probability, but the readily releasable pool is unchanged. by Mallory C. Shields (4474210)

    Published 2017
    “…<p>(A) Mean EJP amplitudes from <i>+/-;P[syt<sup>WT</sup>]/+</i> (filled black circles) and <i>+/-;P[syt<sup>P-L</sup>]/+</i> (filled red circles) larvae at Ca<sup>2+</sup> levels ranging from 0.05 mM—5.0 mM. …”
  16. 1196

    Effect on the metabolic clearance rate (MCR) of meranzin hydrate (MH) under the inhibition of recombinant CYP1A2 and CYP2C19. by Xi Huang (12172)

    Published 2014
    “…The MCRs of MH were significantly decreased compared with that of the control for CYP1A2 and CYP2C19, for both concentrations of MH.…”
  17. 1197

    Advancing the science of NOWS research. by Sarah E. Maylott (14560785)

    Published 2024
    “…It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. …”
  18. 1198

    Protocol measures. by Sarah E. Maylott (14560785)

    Published 2024
    “…It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. …”
  19. 1199

    Cry variables. by Sarah E. Maylott (14560785)

    Published 2024
    “…It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. …”
  20. 1200